InterVenn Biosciences Enters Next Stage with Senior Management Team Updates Focused on Commercialization
Erwin Estigarribia appointed as Chief Executive Officer and Laura Beggrow appointed as Chief Commercial Officer
Erwin Estigarribia appointed as Chief Executive Officer and Laura Beggrow appointed as Chief Commercial Officer